Nixipin-S Injection combines Cefepime and Sulbactam, offering a potent treatment for severe bacterial infections. Cefepime, a fourth-generation cephalosporin, provides broad-spectrum coverage against gram-positive and gram-negative bacteria. Sulbactam acts as a beta-lactamase inhibitor, enhancing the effectiveness of Cefepime by preventing bacterial resistance mechanisms. Administered intravenously, Nixipin-S Injection is crucial in hospital settings for treating complicated infections. It addresses resistant bacterial strains, ensuring effective therapy and patient recovery in critical care scenarios..Available in PCD Franchise for injectable range and third party manufacturing.